News

Month Year

Month Year

Apr 12, 2018

Sanofi to invest €350 million in Canadian vaccine facility

* Expansion demonstrates company’s commitment to innovation and leadership in global public health
Apr 12, 2018

New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels
Apr 11, 2018

/R E P E A T -- Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility/
Apr 10, 2018

Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility
Mar 10, 2018

Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate

Show per page